Overview
- Prenetics priced a best‑efforts public offering of 2,992,596 Class A shares at $16.08 each with pre‑funded options plus Class A and B warrants that are immediately exercisable for five years at $24.12 and $32.16.
- The company expects roughly $48.0 million in gross proceeds, with closing slated for October 28 pending customary conditions.
- Dominari Securities acted as sole placement agent, and the securities were offered under a Form F‑3 shelf registration declared effective by the SEC on September 11.
- Funds are earmarked to expand IM8, the David Beckham‑co‑founded wellness brand that reached $100 million in annual recurring revenue in 11 months.
- Prenetics continues buying roughly 1 BTC per day and held 275 BTC as of October 27; independent reports say investors included Kraken, Exodus, GPTX and American Ventures and that full warrant exercise could lift total proceeds to about $212 million.